Friedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.
Institute of Medical Microbiology, University Hospital Münster, Münster, Germany.
J Clin Microbiol. 2021 Nov 18;59(12):e0181419. doi: 10.1128/JCM.01814-19. Epub 2021 Jun 16.
The advent of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) in clinical microbiology has dramatically improved the accuracy and speed of diagnostics. However, this progress has mainly been limited to the identification of microorganisms, whereas the practical improvement of antimicrobial susceptibility testing (AST) still lags behind. MALDI-TOF MS-based approaches include the detection of selected resistance mechanisms and the universal phenotypic AST. This minireview focuses on the discussion of those MALDI-TOF MS methods that allow universal growth-based phenotypic AST. The method of minimal profile change concentrations (MPCC) is based on detecting proteome modification in the presence of an antimicrobial. Using stable-isotope labeling, characteristic mass shifts in the presence of an antimicrobial indicate the incorporation of the isotopic labels, and thus the viability and resistance of the microorganism. For MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA), microorganisms are incubated with or without an antimicrobial, followed by cell lysis, protein extraction, and transfer of the cell lysate onto a MALDI target plate. Using the internal standard, peak intensities are correlated to the amount of microbial proteins, and the relative microbial growth is calculated. Most recent development in the field is the direct-on-target microdroplet growth assay (DOT-MGA). Here, incubation of microorganisms with antimicrobials takes place directly on spots of a MALDI target in the form of microdroplets. After incubation, nutrient medium is removed by dabbing with absorptive material. Resistant microorganisms grow despite the presence of antimicrobial, and their amplified biomass is detected by MALDI-TOF MS. Finally, an outlook is provided for further assay improvements.
基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)在临床微生物学中的出现极大地提高了诊断的准确性和速度。然而,这一进展主要局限于微生物的鉴定,而抗菌药物敏感性测试(AST)的实际改进仍然滞后。MALDI-TOF MS 方法包括检测选定的耐药机制和通用表型 AST。这篇综述重点讨论了允许通用基于生长表型 AST 的那些 MALDI-TOF MS 方法。最小谱变化浓度(MPCC)方法基于在存在抗菌药物的情况下检测蛋白质组的修饰。使用稳定同位素标记,在存在抗菌药物的情况下,特征质量位移表明同位素标记的掺入,从而表明微生物的活力和耐药性。对于 MALDI Biotyper 抗生素药敏快速检测(MBT-ASTRA),将微生物与或不与抗菌药物孵育,然后进行细胞裂解、蛋白质提取,并将细胞裂解物转移到 MALDI 靶板上。使用内标,峰强度与微生物蛋白质的量相关联,并计算相对微生物生长。该领域的最新发展是直接靶标微滴生长测定(DOT-MGA)。在这里,微生物与抗菌药物的孵育直接以微滴的形式在 MALDI 靶标上的斑点中进行。孵育后,用吸收性材料擦拭除去营养培养基。尽管存在抗菌药物,耐药微生物仍会生长,其扩增的生物量通过 MALDI-TOF MS 检测。最后,对进一步的测定改进提供了展望。